Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Serum lncRNA marker for diagnosis of unexplained recurrent spontaneous abortion, primer group, application and kit

A technology for recurrent miscarriage and unknown diagnosis, applied in the field of genetic engineering, to achieve the effects of easy detection, fast and accurate disease status and severity, and improved sensitivity and specificity

Active Publication Date: 2017-11-10
NANJING MEDICAL UNIV
View PDF2 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] At present, there is no clinical report on the application of lncRNA in the auxiliary diagnosis of recurrent miscarriage. If the lncRNA related to recurrent miscarriage can be screened out as a biomarker for early diagnosis, and the corresponding diagnostic kits can be developed, it will be beneficial to the diagnosis of recurrent miscarriage. The present situation of diagnosis will definitely be a powerful impetus, and it will also open up a new way for its drug screening, drug efficacy evaluation and targeted therapy.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Serum lncRNA marker for diagnosis of unexplained recurrent spontaneous abortion, primer group, application and kit
  • Serum lncRNA marker for diagnosis of unexplained recurrent spontaneous abortion, primer group, application and kit
  • Serum lncRNA marker for diagnosis of unexplained recurrent spontaneous abortion, primer group, application and kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1: lncRNA screening of decidua tissue

[0046] 1 material

[0047] 1.1 Selection of research objects and sample collection

[0048] (1) According to the diagnostic criteria: pregnant women with 2 or more consecutive pregnancy losses before 20 weeks of pregnancy or fetal weight less than 500g are the case group; according to age, gestational weeks, BMI and other indicators, the frequency matching method is used to select children Pregnant women with normal ability and non-medical reasons for miscarriage (without signs and signs of miscarriage, no history of miscarriage, and at least one normal child born) were used as the control group.

[0049] (2) B-ultrasound shows no germ or fetal heartbeat, and abortion caused by factors such as monogenic genetic diseases, polygenic genetic diseases, chromosomal abnormalities, and gene mutations must be excluded.

[0050] (3) Grouping of research objects:

[0051] Group A: the control group of pregnant women who chose abo...

Embodiment 2

[0061] Example 2: Detection of the expression levels of lnc-CHAC1-1, lnc-FMN1-1, lnc-TAX1BP1-4, lnc-C2CD4A-3, lnc-CES1-1, lnc-ATF3-3 in decidua tissue

[0062] 1 material

[0063] 1.1 Selection of research objects and sample collection

[0064] The selection of research objects and sample collection in this embodiment are the same as those in Embodiment 1.

[0065] 1.2 Reagents

[0066] The reagents used in qPCR are the same as in Example 1.

[0067] 2 methods

[0068] 2.1 Extraction of total RNA

[0069] The decidual tissues of 63 cases of normal control group and 63 cases of recurrent abortion cases were taken as objects.

[0070] (1) Take 50-100 mg of decidua tissue and grind it in liquid nitrogen, add 1 mL of TRIzol, homogenize it with a homogenate ultrasonic instrument, and place it at room temperature (15-30°C) for 5 minutes to completely separate the nucleoproteinase. (2) Add 200 μl chloroform for every 1 mL of TRIzol used, shake vigorously for 30 s, and place on ...

Embodiment 3

[0085] Example 3: Detection of expression levels of lnc-CHAC1-1, lnc-FMN1-1, lnc-TAX1BP1-4, lnc-C2CD4A-3, lnc-CES1-1, lnc-ATF3-3 in serum

[0086] 1 material

[0087] 1.1 Selection of research objects and sample collection

[0088] The selection of research objects and sample collection in this embodiment are the same as those in Embodiment 1.

[0089] 1.2 Reagents

[0090] The reagents used in qPCR are the same as in Example 1.

[0091] 2 methods

[0092] 2.1 Extraction of total RNA

[0093] The serum samples of 63 cases of normal control group and 63 cases of recurrent miscarriage case group were taken as objects.

[0094] (1) Take 5ml of fresh heparin anticoagulant blood and centrifuge at 3000rpm for 5min in a centrifuge, take the supernatant and put it into clean 1.5ml EP tubes, 100μl per tube. (2) Add 900 μl TRIzol to the EP tube, shake and mix well, centrifuge at 12,000 rpm for 15 min at 4°C, and immediately transfer the supernatant to a clean 1.5ml EP tube. (3) A...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of gene engineering and relates to a serum lncRNA marker for diagnosis of unexplained recurrent spontaneous abortion, a primer group, application and a kit. The serum lncRNA marker comprises first lncRNA with homology being more than 90 percent with a nucleotide sequence as shown in SEQ ID NO:1, second lncRNA with homology being more than 90 percent with a nucleotide sequence as shown in SEQ ID NO:2, third lncRNA with homology being more than 90 percent with a nucleotide sequence as shown in SEQ ID NO:3, fourth lncRNA with homology being more than 90 percent with a nucleotide sequence as shown in SEQ ID NO:4, fifth lncRNA with homology being more than 90 percent with a nucleotide sequence as shown in SEQ ID NO:5 and sixth lncRNA with homology being more than 90 percent with a nucleotide sequence as shown in SEQ ID NO:6. The serum lncRNA marker is a novel biomarker and can greatly improve the sensitivity and the specificity of diagnosis of recurrent spontaneous abortion.

Description

technical field [0001] The invention belongs to the field of genetic engineering, and more specifically relates to a serum lncRNA marker, a primer set, an application and a kit for diagnosing unexplained recurrent miscarriage. Background technique [0002] Recurrent spontaneous abortion (RSA) refers to clinically two or more consecutive pregnancy losses before 20W or fetal weight less than 500g, and its incidence rate accounts for about 1% to 3% of pregnancy outcomes. The etiology of RSA is extremely complex, and the etiology that has been identified so far includes chromosomal abnormalities, abnormal reproductive anatomical structures, endocrine disorders, reproductive system infections, autoimmunity, and environmental factors, but there are still 50% to 60% of RSA cases that cannot be identified clinically. It is called unexplained recurrent spontaneous abortion (URSA). Studies have shown that abnormal embryonic development is closely related to URSA. As a pathological p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/68C12N15/11
CPCC12Q1/6883C12Q2600/158C12Q2600/178
Inventor 陆春城范赟黄振遥于明明杜桂珍傅广波夏彦恺王心如
Owner NANJING MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com